 |
|
| Product ID |
Structure |
Product Name |
Purity |
Price(s) |
Delete |
| D511650 |
 |
(-)-Bilobalide |
98%
|
$240/1g, $750/5g, $1200/10g, $1500/12g |
 |
| Y3105043 |
 |
(2S,3S)-3-Amino-2-butanol |
95%
|
$495/50mg, $725/100mg, $1030/250mg, $1615/500mg, $2075/1g, $4055/2.5g, $6000/5g |
|
| D552927 |
 |
(2S,4R)-1-tert-Butyl 2-Methyl 4-((Methylsulfonyl)oxy)pyrrolidine-1,2-dicarboxylate |
97%
|
$450/10g |
|
| Y1299170 |
 |
(8S)-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid;hydrobromide |
97%
|
$110/100mg, $140/250MG, $215/500MG, $310/1G, $930/5G, $1550/10G, $3105/25G, $4655/50G |
|
| Y4005046 |
 |
(R)-2-(3-Chlorophenyl)-4,5-dihydrothiazole-4-carboxylic Acid |
95%
|
|
|
| D556806 |
 |
[1]Benzothieno[3'',2'':4',5']thieno[2',3':4,5]thieno[2,3-b][1]benzothiophene |
96%
|
$2215/1g, $7815/10g |
|
| D509788 |
 |
1,3-Dichloro-2-iodo-5-(trifluoroMethyl)benzene |
97%
|
$225/5g |
|
| D497122 |
 |
1-[(tert-butoxy)carbonyl]-4-fluoropiperidine-4-carboxylic acid |
97%
|
$120/5G, $215/10G, $330/25G, $560/50G, $955/100G, $2100/250G |
|
| Y1255966 |
 |
2',4',5'-Trifluoroacetophenone oxime |
98%
|
$205/250mg, $310/1g, $960/5g, $3645/25g |
|
| Y1200765 |
 |
2,4-Dichlorobenzenesulfinic acid sodium salt |
95%
|
$385/1g, $655/5g |
|
| Y1317636 |
 |
2-amino-3-pyrimidin-5-yl-propanoic acid;dihydrochloride |
97%
|
$425/100mg, $680/250MG, $1120/500MG, $1695/1G |
|
| D523490 |
 |
2-Bibenzylcarboxylic acid |
97%
|
$110/1g, $170/5g, $180/10g, $210/25g |
|
| D593486 |
 |
2-Fluoro-2-(3-fluorophenyl)acetonitrile |
95%
|
$390/1g |
|
| Y3132756 |
 |
2-methyl-5-[(3-methylphenyl)sulfamoyl]benzoic acid |
98%
|
$125/50mg, $160/100mg, $175/250mg, $300/500mg, $430/1g, $815/2.5g, $1205/5g |
|
| Y1234457 |
 |
2-Pyridinecarbonitrile, 5-chloro-3-hydroxy- |
95%
|
$505/100mg, $750/250mg, $1760/1g |
|
| D658644 |
 |
2-tert-butyl-4,5-dichloro-2,3-dihydropyridazin-3-one |
97%
|
$110/5G, $190/10G, $335/25G, $675/50G, $1350/100G |
|
| D381301 |
 |
3,6-Dibromo-phenanthrenequinone |
97%
|
$120/1g, $145/10g, $175/25g, $470/100g |
|
| Y1316678 |
 |
3,6-difluoro-2-nitrophenol |
97%
|
$90/250MG, $120/500MG, $180/1G, $565/5G, $1090/10G, $2730/25G |
|
| Y1366826 |
 |
3-(4-Isopropyl-4H-1,2,4-triazol-3-yl)aniline |
98%
|
$250/100mg, $425/250mg, $1150/1g |
|
| Y4018257 |
 |
3-{[(6-methylcyclohex-3-en-1-yl)methoxy]methyl}benzoic acid |
95%
|
$520/1g, $1515/5g |
|
| D498376 |
 |
3-amino-1,2-dihydroquinoxalin-2-one |
97%
|
$365/1G, $1200/5G, $1800/10G |
|
| D691322 |
 |
3-Amino-3-(4-methylphenyl)propionic Acid |
>97%
|
$40/1g, $50/5g, $65/10g, $80/25g |
|
| Y1472613 |
 |
4-(2-Aminoethyl)-3-chlorophenol |
95%
|
$625/1g, $795/2g |
|
| Y3148794 |
 |
4-{[(tert-butoxy)carbonyl]amino}hexanoic acid |
95%
|
$275/50mg, $405/100mg, $565/250mg, $885/500mg, $1135/1g |
|
| Y1445469 |
 |
4-oxobutanenitrile |
97%
|
$165/100mg, $215/250MG, $345/500MG, $515/1G |
|
| D340425 |
 |
5,6-Dichloropyrazine-2,3-dicarboxylic acid |
97%
|
$500/1g, $1380/5g, $1980/10g, $3000/25g |
|
| Y1210577 |
 |
5-methoxypyrazin-2-amine |
97%
|
$225/5G, $425/10G |
|
| Y3148497 |
 |
5-phenyl-1,3,4-thiadiazole-2-carbonitrile |
95%
|
$305/50mg, $450/100mg, $625/250mg, $975/500mg, $1250/1g, $2440/2.5g, $3610/5g |
|
| Y3269743 |
 |
Benzene, 1-bromo-4-(phenylmethoxy)-2-(trifluoromethoxy)- |
95%
|
$350/1g, $1020/5g |
|
| D380906 |
 |
Bucillamine |
97%
98%ee |
$490/100mg, $970/250mg, $2300/1g |
|
| Y3230070 |
 |
Chloro(4-cyanophenyl){(R)-1-[(S)-2-(dicyclohexylphosphino)ferrocenyl]ethyl (dicyclohexylphosphine)}nickel(II) |
95%
|
$510/250mg |
|
| Y0979719 |
 |
chroman-2-ol |
95%
|
$1000/1g |
|
| Y3183408 |
 |
ethyl 5-(piperidin-4-yl)-1,3-oxazole-4-carboxylate hydrochloride |
95%
|
$395/50mg, $570/100mg, $810/250mg, $1275/500mg, $1635/1g, $3195/2.5g |
|
| Y1052770 |
 |
Saclofen |
98%
|
$486/50mg |
|
| Y1491560 |
 |
tert-butyl (1S,5S)-2,6-diazabicyclo[3.2.0]heptane-2-carboxylate |
95%
|
$1980/1g |
|
| Y1261662 |
 |
tert-butyl (2-oxo-1-azaspiro[4.5]decan-8-yl)carbamate |
95%
|
|
|
| Y1447338 |
 |
trans-5-methyl-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrole;dihydrochloride |
97%
|
$480/100mg, $720/250MG, $960/500MG, $1205/1G |
|
|
|
|
|
|
|